The serum CP levels were elevated in lung cancer, colon carcinoma, epithelial ovarian cancer (42–44), and correlated with invasiveness of cancer cells, while in adrenocortical and hepatocellular carcinoma, the expression levels of CP were down-regulated (45, 46). This evidence concerns the gene CP and lung carcinoma.